Justin "Jay" Bader, MD

2026

• Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma

  Bader JM, Dhiman A, Aguirre N, Ofori KA, Gupta P, Qin H, Sharma A, Mitchell O, Tjota MY, Husain AN, Drazer M, Churpek J, Kindler H, Turaga K. Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma. Npj Precision Oncology 2026 DOI: 10.1038/s41698-026-01495-x.

  Peer-Reviewed Original Research

  This study investigates the prognostic impact of somatic mutations in mesothelioma, showing NF2 truncating variants worsen survival, supporting genomic testing to guide treatment strategies.

  Full Summary

• A Personalized Prediction Model for Postcontrast Acute Kidney Injury After Peripheral Vascular Intervention

  Phu T, Wang C, Bader J, Huang Y, Slade M, Aboian E, Zwibelman H, Cardella J, Guzman R, Chaar C. A Personalized Prediction Model for Postcontrast Acute Kidney Injury After Peripheral Vascular Intervention. Journal Of Vascular Surgery 2026, 84: e161-e162. DOI: 10.1016/j.jvs.2026.03.244.

  Peer-Reviewed Original Research

• Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance

  Ofori K, Smart H, Liu S, Bader J, Aguirre N, Gupta P, Sharma A, Turaga K. Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance. Annals Of Surgical Oncology 2026, 1-4. PMID: 42265516, DOI: 10.1245/s10434-026-19903-8.

  Peer-Reviewed Original Research

  Citations

  Concepts

• CEACAM5 as a biomarker of semi-solid, lepidic lung adenocarcinoma

  Bader, J. M., de Santis, W., Ermer, T., & Woodard, G. A. (2026). CEACAM5 as a biomarker of semi-solid, lepidic lung adenocarcinoma. Translational Lung Cancer Research, 15(5).

  Peer-Reviewed Original Research

• Associations of autoimmune diseases with appendiceal cancer in a population-based study.

  Ofori K, Bader J, Reddy B, Aguirre N, Gupta P, Sharma A, Godfrey E, Ong C, Cecchini M, Sundar R, Turaga K. Associations of autoimmune diseases with appendiceal cancer in a population-based study. Journal Of Clinical Oncology 2026, 44: e16495-e16495. DOI: 10.1200/jco.2026.44.16_suppl.e16495.

  Peer-Reviewed Original Research

  Concepts

• Natural History, Treatment, Survival, and Causes of Mortality in Patients With Subsolid and Ground-Glass Nodules

  Justin M. Bader, Samantha R. Prince, William de Santis, Emma R. Kane, Lynn Tanoue, Anna S. Bader, Justin D. Blasberg, Frank C. Detterbeck, Gavitt A. Woodard, Natural History, Treatment, Survival, and Causes of Mortality in Patients With Subsolid and Ground-Glass Nodules, CHEST, 2026, ISSN 0012-3692

  Peer-Reviewed Original Research

• Natural history, treatment, survival, and causes of mortality in patients with subsolid and ground-glass nodules

  Bader J, Prince S, de Santis W, Kane E, Tanoue L, Bader A, Blasberg J, Detterbeck F, Woodard G. Natural history, treatment, survival, and causes of mortality in patients with subsolid and ground-glass nodules. Chest 2026 PMID: 42155700, DOI: 10.1016/j.chest.2026.04.053.

  Peer-Reviewed Original Research

  Altmetric

  Concepts

• Radiographic tumor regression as a predictor for pathologic response after neoadjuvant therapy for non–small cell lung cancer

  Bader JM, Ermer T, de Santis W, Ragoowansi H, Kramer RJ, Zolfaghari EJ, Tremblay EE, Resio BJ, Boffa DJ, Blasberg JD, Bader AS, Dacic S, Woodard GA. Radiographic tumor regression as a predictor for pathologic response after neoadjuvant therapy for non–small cell lung cancer. JTCVS Open 2026, 101831. DOI: 10.1016/j.xjon.2026.101831.

  Peer-Reviewed Original Research

• RF79. Radiographic Tumor Regression as a Predictor for Pathologic Response after Neoadjuvant Therapy for Non-Small Cell Lung Cancer

  Bader J, De Santis W, Ermer T, Kramer R, Boffa D, Blasberg J, Resio B, Bader A, Dacic S, Woodard G. RF79. Radiographic Tumor Regression as a Predictor for Pathologic Response after Neoadjuvant Therapy for Non-Small Cell Lung Cancer. Journal Of Thoracic And Cardiovascular Surgery 2026, 171: s164. DOI: 10.1016/j.jtcvs.2026.03.527.

  Peer-Reviewed Original Research

  Concepts

• Radiographic Tumor Regression as a Predictor for Pathologic Response after Neoadjuvant Therapy for Non-Small Cell Lung Cancer

  Bader J, Ermer T, de Santis W, Ragoowansi H, Kramer R, Zolfaghari E, Tremblay E, Resio B, Boffa D, Blasberg J, Bader A, Dacic S, Woodard G. Radiographic Tumor Regression as a Predictor for Pathologic Response after Neoadjuvant Therapy for Non-Small Cell Lung Cancer. JTCVS Open 2026, 101831. DOI: 10.1016/j.xjon.2026.101831.

  Peer-Reviewed Original Research

  Altmetric

  Concepts